PACB – pacific biosciences of california, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PACB

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

08:07 am

pacb

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at UBS Group AG to a "hold" rating.

Medium Report

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at UBS Group AG to a "hold" rating.

Report

11/11

02:04 pm

pacb

Rating for PACB

Low Report

Rating for PACB

Report

11/11

01:58 pm

pacb

Rating for PACB

Medium Report

Rating for PACB

Report

11/11

01:58 pm

pacb

Rating for PACB

Medium Report

Rating for PACB

Report

11/11

10:15 am

pacb

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

High Report

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

Report

8/28

10:47 am

pacb

Rating for PACB

Medium Report

Rating for PACB

Report

8/28

10:47 am

pacb

Rating for PACB

Medium Report

Rating for PACB

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.